Silo Pharma
SILO
9 hedge funds and large institutions have $1.22M invested in Silo Pharma in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
427% more capital invested
Capital invested by funds: $231K → $1.22M (+$988K)
0.08% less ownership
Funds ownership: 0.34% → 0.26% (-0.08%)
10% less funds holding
Funds holding: 10 → 9 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$51.5K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$18.4K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.09K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Mariner
Overland Park,
Kansas
| $1M | – | – | – |
|
|
FAIM
2
Financial Advocates Investment Management
Olympia,
Washington
| $122K | – | – | – |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $31.9K | – | – | – |
|
4
Geode Capital Management
Boston,
Massachusetts
| $31.1K | – | – | – |
|
5
State Street
Boston,
Massachusetts
| $24K | – | – | – |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $8.64K | -$4.09K | -172 | -37% |
|
|
7
UBS Group
Zurich,
Switzerland
| $729 | -$51.5K | -2,165 | -99% |
|
|
WIM
8
Westside Investment Management
Santa Monica,
California
| $183 | – | – | – |
|
|
FIM
9
FWL Investment Management
Dallas,
Texas
| $156 | – | – | – |
|
10
Wells Fargo
San Francisco,
California
| $33 | – | – | – |
|
11
JP Morgan Chase
New York
| $2 | – | – | – |
|
|
TSS
12
Two Sigma Securities
New York
| – | -$18.4K | -853 | Closed |
|
SILO Hedge Fund Activity: Q1 2024 in Review
9 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Silo Pharma (SILO) for Q1 2024, worth a combined $1.22M — up 427% from $231K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of SILO and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest seller was UBS Group, cutting an estimated $51.5K.
- 9 institutional investors held Silo Pharma (SILO) as of Q1 2024, down from 10 in Q4 2023.
- Funds reported $1.22M of Silo Pharma stock for Q1 2024, up 427% quarter-over-quarter.
- 0 funds opened new Silo Pharma positions in Q1 2024 and 1 closed out, a net change of -1 holder.
- The largest Silo Pharma seller in Q1 2024 was UBS Group, an estimated $51.5K sold.
Based on aggregated 13F filings for Q1 2024.